INBX
Inhibrx Biosciences, Inc. · Healthcare
Director Jon Faiz Kayyem bought $500K of Inhibrx Biosciences, Inc.
Bought$500,000
$100.00Price
5,000Shares
+1%Stake
What INBX did for a copier
- $1,000 copied at Fri, Sep 18 open, $106.45
- $877
- S&P 500, same days
- −0.2%
25 of 30 trading days so far, to the Oct 23 close.
Jon Faiz Kayyem's record
3 other buys with 3 months of prices since 2024: on average −10.6% against the S&P 500, and 0 of 3 beat it.
We're building an app that can copy buys like this into your own brokerage. Join the waitlist
Traded Wed, Sep 16. Filed Thu, Sep 17, 5:46 PM ET, after the close. Returns use the Sep 18 open and the Oct 23 close. Not investment advice.